Tom Armstrong

Docking-Based Virtual Screening Enables Prioritizing Protein Kinase Inhibitors With In Vitro Phenotypic Activity Against Schistosoma mansoni

Naiara Clemente Tavares, Sandra Grossi Gava, Gabriella Parreiras Torres, 2022, Frontiers in Cellular and Infection Microbiology.

JMM Profile: Carbapenems: a broad-spectrum antibiotic

K. Hardie, Tom Armstrong, S. Fenn, 2021, Journal of medical microbiology.

Use of BODIPY-Labeled ATP Analogues in the Development and Validation of a Fluorescence Polarization-Based Assay for Screening of Kinase Inhibitors

L. Dekker, Bernardo P. Moreira, Franco H Falcone, 2020, ACS omega.

New InhA Inhibitors Based on Expanded Triclosan and Di-Triclosan Analogues to Develop a New Treatment for Tuberculosis

S. Bhakta, Sarentha Chetty, D. Evangelopoulos, 2021, Pharmaceuticals.

Inhibition of Mycobacterium tuberculosis InhA: Design, synthesis and evaluation of new di-triclosan derivatives.

L. Alderwick, N. R. Thomas, M. Lamont, 2020, Bioorganic & medicinal chemistry.